Semaglutide is mostly effectively tolerated with identical dropout rates compared with placebo, even though it may very well be significantly less well tolerated than dulaglutide (Trulicity).one,3 The most common adverse outcomes are nausea, vomiting, and diarrhea and may be knowledgeable by about thirty% of clients, typically when the dose is incr